How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 322-327

  Hutchings, Martin ^a  

^a FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

COMPUTER ASSISTED TOMOGRAPHY; DECISION SUPPORT SYSTEM; HODGKIN DISEASE; HUMAN; METHODOLOGY; ONCOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; REVIEW; RISK; SCINTISCANNING; TREATMENT OUTCOME;

DECISION SUPPORT SYSTEMS, CLINICAL; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MEDICAL ONCOLOGY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84879380222     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.322.3800161     Document Type: Review

References (0)